(Q40341132)

19 September 2017

title

Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma (English)

1 reference

19 September 2017

0 references

Senji Tafuku

1

1 reference

19 September 2017

Takehiro Matsuda

2

1 reference

19 September 2017

Hirochika Kawakami

3

1 reference

19 September 2017

Mariko Tomita

4

1 reference

19 September 2017

Hideo Yagita

5

1 reference

19 September 2017

Naoki Mori

6

1 reference

19 September 2017

publication date

1 January 2006

1 reference

European Journal of Haematology

19 September 2017

published in

1 reference

19 September 2017

volume

76

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

64-74

1 reference

Regulation of proliferation, survival and apoptosis by members of the TNF superfamily

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Tumor necrosis factor-related apoptosis-inducing ligand and its receptor expression and the pathway of apoptosis in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Transactivation of the CCL5/RANTES gene by Epstein-Barr virus latent membrane protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Inhibition of death receptor signals by cellular FLIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Apo2L/TRAIL and its death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Transcriptional activation of survivin through the NF-kappaB pathway by human T-cell leukemia virus type I tax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.0000.T01-1-EJH2345.X

10.1111/J.0902-4441.0000.T01-1-EJH2345.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference